Yıldız, O. (2026) “Reduced efficacy of nivolumab following prior immunotherapy in metastatic renal cell carcinoma: Implications for sequential immune checkpoint inhibition”, EXPERIMENTAL BIOMEDICAL RESEARCH, 9(1), pp. 1–9. doi: 10.30714/j-ebr.2026.262.